Processa Pharmaceuticals Inc
Research Processa Pharmaceuticals Inc (PCSA) on Bullrun: market cap USD 5.84M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPCSA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 5.84M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 3.38M
- Free cash flow-USD 13.10M
Valuation Snapshot
latest market cap is USD 5.84M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 13.56M | -USD 12.24M | n/a | -10.36 | USD 5.54M | USD 0 | USD 5.58M |
| FY2024 | USD 0 | -USD 11.85M | -USD 11.25M | n/a | -96.78 | USD 1.19M | USD 73.51K | USD 1.70M |
| FY2023 | USD 0 | -USD 11.12M | -USD 8.07M | n/a | -8.48 | USD 4.71M | USD 150.55K | USD 4.99M |
| FY2022 | USD 0 | -USD 27.42M | n/a | n/a | -34.05 | USD 6.50M | USD 31.21K | USD 7.47M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 5.84M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 6.53M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 3.27M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 8.26M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 17.60M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 76.93M | n/a | n/a | n/a |
About Processa Pharmaceuticals Inc
Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Processa Pharmaceuticals Inc's market cap?
Processa Pharmaceuticals Inc's market capitalization is USD 5.84M.
What does Processa Pharmaceuticals Inc do?
Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells.